News
#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, '#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its Post Marketing Surveillance (PMS) study on #Favipiravir in India. Photo: IANS (File)'
#Glenmark Pharmaceuticals on Tuesday announced its interim data of 503 patients from its Post Marketing Surveillance (PMS) study on #Favipiravir in India.
Photo: IANS (File) pic.twitter.com/LTcdh73NxU— IANS Tweets (@ians_india) June 8, 2021
(The above story first appeared on LatestLY on Jun 08, 2021 07:42 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
